The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Open accessAbstract
For several decades scientists have speculated that the key to understanding age-related neurodegenerative disorders may be found in the unusual biology of the prion diseases. Recently, owing largely to the advent of new disease models, this hypothesis has gained experimental momentum. In a remarkable variety of diseases, specific proteins have been found to misfold and aggregate into seeds that structurally corrupt like proteins, causing them to aggregate and form pathogenic assemblies ranging from small oligomers to large masses of amyloid. Proteinaceous seeds can therefore serve as self-propagating agents for the instigation and progression of disease. Alzheimer's disease and other cerebral proteopathies seem to arise from the de novo misfolding and sustained corruption of endogenous proteins, whereas prion diseases can also be infectious in origin. However, the outcome in all cases is the functional compromise of the nervous system, because the aggregated proteins gain a toxic function and/or lose their normal function. As a unifying pathogenic principle, the prion paradigm suggests broadly relevant therapeutic directions for a large class of currently intractable diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The recent discovery that specific misfolded and aggregated proteins can propagate and spread in a prion-like fashion has sparked considerable interest (67).”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [67]
In the citing paper
“In Parkinson’s disease and Lewy body disease, α-synuclein aggregates initially spread through the brainstem and olfactory bulb followed by limbic structures, and only thence to the neocortex.”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [67]
In the citing paper
“In each of these cases, the aggregates initially deposit at the ventral base of the forebrain and midbrain, and then extend rostrally and dorsally to the cortex.”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [67]
In the citing paper
“While still a contentious topic [46], there is now substantial evidence that also supports the idea that propagation of pathological tau species occurs between cells [47–50].”
From Glial contributions to neurodegeneration in tauopathies (2017) · cites this paper as [50]
In the citing paper
“As aforementioned, the neuropathological lesions of not only AD but also PD/DLB and amyotrophic lateral sclerosis (ALS) are known to spread through the brain in a rather specific pattern, which also serves as a basis for the neuropathological staging of disease severity [203].”
From α-synuclein in the pathophysiology of Alzheimer’s disease (2019) · cites this paper as [203]
In the citing paper
“Importantly, the spatiotemporal spread of αSyn lesions in PD/DLB is nearly inverted to the spread of Aβ and tau pathology as observed in AD [203].”
From α-synuclein in the pathophysiology of Alzheimer’s disease (2019) · cites this paper as [203]
In the citing paper
“pathological neurofibrillary Tau aggregates show a pattern of accumulation that starts in the entorhinal cortex and spreads through connected pathways to cortical areas (Jucker and Walker, 2013)”
From Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer’s Disease (2020) · cites this paper as Jucker and Walker, 2013
In the citing paper
“It has been suggested that alpha-synuclein could act like a prion protein during PD pathogenesis.In this theory pathologic, misfolded alpha-synuclein is an 'infectious' protein spreading pathology by forming a template that seeds misfolding for nearby alpha-synuclein protein, turning the previously healthy protein into a pathogenic protein (Jucker and Walker, 2013;Visanji et al., 2013).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Jucker and Walker, 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,497
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Molecular chaperones in protein folding and proteostasis
Hartl, F. U., Bracher, A., & Hayer-Hartl, M. (2011) · Nature · doi:10.1038/nature10317 · Cited by 3,381
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Adapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495
Cited by
Sorted by citations
Items 301–400 of 1,000
Bacterial DNA promotes Tau aggregation
Tetz, G. V., Pinho, M. A., Pritzkow, S., Méndez, N., Soto, C. A., & Tetz, V. (2020) · Scientific Reports · doi:10.1038/s41598-020-59364-x · Cited by 81
Glymphatic function plays a protective role in ageing-related cognitive decline
Wang, J., Zhou, Y., Zhang, K., Wang, R., Xiao, Z., Zhong, W., Chen, Y., Li, J., Sun, J., & Lou, M. (2023) · Age and Ageing · doi:10.1093/ageing/afad107 · Cited by 80
Fate and propagation of endogenously formed Tau aggregates in neuronal cells
Chastagner, P., Loría, F., Vargas, J., Tois, J., Diamond, M. I., Okafo, G. N., Brou, C., & Zurzolo, C. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012025 · Cited by 80
Huang, C., Wagner-Valladolid, S., Stephens, A. D., Jung, R., Poudel, C., Sinnige, T., Lechler, M. C., Schlörit, N., Lü, M., Laine, R. F., et al. (2019) · eLife · doi:10.7554/elife.43059 · Cited by 79
Highly potent soluble amyloid-β seeds in human Alzheimer brain but not cerebrospinal fluid
Fritschi, S. K., Langer, F., Kaeser, S. A., Maia, L. F., Portelius, E., Pinotsi, D., Kaminski, C. F., Winkler, D. T., Maetzler, W., Keyvani, K., et al. (2014) · Brain · doi:10.1093/brain/awu255 · Cited by 83
Self-citationMicrobiota and neurodegenerative diseases
Marizzoni, M., Provasi, S., Cattaneo, A., & Frisoni, G. B. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000496 · Cited by 79
Deep Brain Stimulation of the Nucleus Basalis of Meynert in Early Stage of Alzheimer's Dementia
Kuhn, J., Hardenacke, K., Shubina, E., Lenartz, D., Visser-Vandewalle, V. E. R. M., Zilles, K., Sturm, V., & Freund, H. (2015) · Brain stimulation · doi:10.1016/j.brs.2015.04.002 · Cited by 78
Dadar, M., Manera, A. L., Ducharme, S., & Collins, D. L. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.11.007 · Cited by 78
Runfola, M., Simone, A. D., Vendruscolo, M., Dobson, C. M., & Fusco, G. (2020) · Scientific Reports · doi:10.1038/s41598-019-57023-4 · Cited by 78
Propagation of aggregated p53: Cross-reaction and coaggregation vs. seeding
Wang, G., & Fersht, A. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500262112 · Cited by 77
The N-terminus of the prion protein is a toxic effector regulated by the C-terminus
Wu, B., McDonald, A. J., Markham, K., Rich, C. B., McHugh, K. P., Tatzelt, J., Colby, D. W., Millhauser, G. L., & Harris, D. A. (2017) · eLife · doi:10.7554/elife.23473 · Cited by 77
Aβ truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition
Cabrera, E., Mathews, P. M., Mezhericher, E., Beach, T. G., Deng, J., Neubert, T. A., Rostagno, A. A., & Ghiso, J. A. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.005 · Cited by 78
Sun, Y., Käkinen, A., Wan, X., Moriarty, N., Hunt, C. J., Li, Y., Andrikopoulos, N., Nandakumar, A., Davis, T. P., Parish, C. L., et al. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101125 · Cited by 76
Holmes, W. E., Angel, T. E., Li, K. W., & Hellerstein, M. K. (2015) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2015.05.018 · Cited by 78
Design of multi-phase dynamic chemical networks
Chen, C., Tan, J., Hsieh, M.-C., Pan, T., Goodwin, J. T., Mehta, A. K., Grover, M. A., & Lynn, D. G. (2017) · Nature Chemistry · doi:10.1038/nchem.2737 · Cited by 76
Brain structural alterations are distributed following functional, anatomic and genetic connectivity
Cauda, F., Nani, A., Manuello, J., Premi, E., Palermo, S., Tatu, K., Duca, S., Fox, P. T., & Costa, T. (2018) · Brain · doi:10.1093/brain/awy252 · Cited by 77
Gorges, M., Roselli, F., Müller, H.-P., Ludolph, A. C., Rasche, V., & Kassubek, J. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00200 · Cited by 76
SOD1 protein aggregates stimulate macropinocytosis in neurons to facilitate their propagation
Zeineddine, R., Pundavela, J., Corcoran, L., Stewart, E. M., Do‐Ha, D., Bax, M., Guillemin, G. J., Vine, K. L., Hatters, D. M., Ecroyd, H. W., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0053-4 · Cited by 75
Seed-induced acceleration of amyloid-β mediated neurotoxicity in vivo
Sowade, R. F., & Jahn, T. R. (2017) · Nature Communications · doi:10.1038/s41467-017-00579-4 · Cited by 78
Propagation of tau and α-synuclein in the brain: therapeutic potential of the glymphatic system
Lopes, D. M., Llewellyn, S. K., & Harrison, I. F. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00293-2 · Cited by 75
Serpin Signatures in Prion and Alzheimer’s Diseases
Zattoni, M., Mearelli, M., Vanni, S., Baldeschi, A. C., Tran, T. H., Ferracin, C., Catania, M., Moda, F., Fede, G. D., Giaccone, G., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02817-3 · Cited by 75
Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex
Sepulcre, J., Grothe, M. J., Sabuncu, M., Chhatwal, J., Schultz, A. P., Hanseeuw, B., El Fakhri, G., Sperling, R., & Johnson, K. A. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.0263 · Cited by 73
Revisiting supersaturation as a factor determining amyloid fibrillation
So, M., Hall, D. R., & Goto, Y. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2015.11.009 · Cited by 76
Engineering enhanced protein disaggregases for neurodegenerative disease
Jackrel, M. E., & Shorter, J. (2015) · Prion · doi:10.1080/19336896.2015.1020277 · Cited by 73
Altered mRNP granule dynamics in FTLD pathogenesis
Bowden, H. A., & Dormann, D. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13601 · Cited by 75
Hasegawa, M. (2016) · Biomolecules · doi:10.3390/biom6020024 · Cited by 75
New insights into mechanisms of small vessel disease stroke from genetics
Tan, R. Y. Y., Traylor, M., Rutten‐Jacobs, L. C. A., & Markus, H. S. (2017) · Clinical Science · doi:10.1042/cs20160825 · Cited by 75
Prions activate a p38 MAPK synaptotoxic signaling pathway
Fang, C., Wu, B., Le, N. T. T., Imberdis, T., Mercer, R. C. C., & Harris, D. A. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007283 · Cited by 74
Toxic Tau Oligomers Modulated by Novel Curcumin Derivatives
Cascio, F. L., Puangmalai, N., Ellsworth, A., Bucchieri, F., Pace, A., Piccionello, A. P., & Kayed, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-55419-w · Cited by 73
Molecular and genetic inflammation networks in major human diseases
Zhao, Y., Forst, C. V., Sayegh, C. E., Wang, I., Yang, X., & Zhang, B. (2016) · Molecular BioSystems · doi:10.1039/c6mb00240d · Cited by 72
De novo design of a biologically active amyloid
Gallardo, R. U., Ramakers, M., Smet, F. D., Claes, F., Khodaparast, L., Khodaparast, L., Couceiro, J. R., Langenberg, T., Siemons, M., Nyström, S., et al. (2016) · Science · doi:10.1126/science.aah4949 · Cited by 72
Metallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies
Okita, Y., Rcom-H'cheo-Gauthier, A. N., Goulding, M., Chung, R. S., Faller, P., & Pountney, D. L. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00114 · Cited by 73
Quinolinic Acid Amyloid-like Fibrillar Assemblies Seed α-Synuclein Aggregation
Tavassoly, O., Sade, D., Bera, S., Shaham‐Niv, S., Vocadlo, D. J., & Gazit, E. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.08.002 · Cited by 71
Role of CXCL10 in central nervous system inflammation
McKimmie, C. S., & Michlmayr, D. (2014) · International Journal of Interferon Cytokine and Mediator Research · doi:10.2147/ijicmr.s35953 · Cited by 71
Vitamin E and Its Molecular Effects in Experimental Models of Neurodegenerative Diseases
Germano, B. C. D. C., de Morais, L. C. C., Neta, F. I., Fernandes, A. C. L., Pinheiro, F. I., do Rêgo, A. C. M., Araújo-Filho, I., de Azevedo, E. P., Cavalcanti, J. R. L. D. P., Gúzen, F. P., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311191 · Cited by 70
Argyrophilic grain disease: An underestimated tauopathy
Rodriguez, R. D., & Grinberg, L. T. (2015) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642015dn91000002 · Cited by 75
Deleglise, B., Magnifico, S., Duplus, E., Vaur, P., Soubeyre, V., Belle, M., Vignes, M., Viovy, J., Jacotot, E. D., Peyrin, J., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0145-3 · Cited by 70
Cremades, N., & Dobson, C. M. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.07.009 · Cited by 72
Are exosomes the vehicle for protein aggregate propagation in neurodegenerative diseases?
Lim, Y.-J., & Lee, S.-J. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0467-z · Cited by 70
Mutlu, J., Landeau, B., Gaubert, M., Sayette, V. D. L., Desgranges, B., & Chételat, G. (2017) · Brain · doi:10.1093/brain/awx279 · Cited by 71
Furcila, D., DeFelipe, J., & Alonso‐Nanclares, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180173 · Cited by 73
Cryo-EM structures of lipidic fibrils of amyloid-β (1-40)
Frieg, B., Han, M., Giller, K., Dienemann, C., Riedel, D., Becker, S., Andreas, L. B., Griesinger, C., & Schroeder, G. F. (2024) · Nature Communications · doi:10.1038/s41467-023-43822-x · Cited by 72
Katt, M. E., Mayo, L. N., Ellis, S., Mahairaki, V., Rothstein, J. D., Cheng, L., & Searson, P. C. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0139-4 · Cited by 69
Role of exosomes in the pathogenesis of inflammation in Parkinson’s disease
Yang, X., Li, K., Huang, H., & Ren, H. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335143 · Cited by 68
Resting-state global brain activity affects early β-amyloid accumulation in default mode network
Han, F., Liu, X., Mailman, R. B., Huang, X., Liu, X., & Initiative, T. A. D. N. (2023) · Nature Communications · doi:10.1038/s41467-023-43627-y · Cited by 68
Aβ seeds resist inactivation by formaldehyde
Fritschi, S. K., Cintron, A. F., Ye, L., Mahler, J., Bühler, A., Baumann, F., Neumann, M., Nilsson, K. P. R., Hammarström, P., Walker, L. C., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1339-2 · Cited by 71
Self-citationNanoscopic insights into seeding mechanisms and toxicity of α-synuclein species in neurons
Pinotsi, D., Michel, C. H., Buell, A. K., Laine, R. F., Mahou, P., Dobson, C. M., Kaminski, C. F., & Schierle, G. S. K. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516546113 · Cited by 68
Holdase activity of secreted Hsp70 masks amyloid-β42 neurotoxicity in Drosophila
Fernández-Fúnez, P., Sanchez-Garcia, J., de Mena, L., Zhang, Y., Levites, Y., Khare, S., Golde, T. E., & Rincón-Limas, D. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608045113 · Cited by 69
Goiran, T., Duplan, E., Chami, M., Bourgeois, A., Manaa, W. E., Rouland, L., Dunys, J., Lauritzen, I., You, H., Stambolic, V., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.04.011 · Cited by 68
Circadian and Sleep Dysfunctions in Neurodegenerative Disorders—An Update
Fifel, K., & Videnović, A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.627330 · Cited by 71
A novel and rapid method for obtaining high titre intact prion strains from mammalian brain
Wenborn, A., Terry, C., Gros, N., Joiner, S., D’Castro, L., Panico, S., Sells, J., Cronier, S., Linehan, J. M., Brandner, S., et al. (2015) · Scientific Reports · doi:10.1038/srep10062 · Cited by 67
Bar‐Yosef, D. L., Sade, D., Shaham‐Niv, S., Zaguri, D., Gartner, M., Basavalingappa, V., Raveh, A., Pichinuk, E., Engel, H., Iwasaki, K., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07966-5 · Cited by 67
Shi, Y., Lu, X., Zhang, L., Shu, H., Gu, L., Wang, Z., Gao, L., Zhu, J., Zhang, H., Zhou, D., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00095 · Cited by 67
Regulation of neuronal autophagy and the implications in neurodegenerative diseases
Cai, Q., & Ganesan, D. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105582 · Cited by 70
Investigating the Intrinsic Aggregation Potential of Evolutionarily Conserved Segments in p53
Ghosh, S., Ghosh, D., Ranganathan, S., Arunagiri, A., Palanirajan, S. K., Jha, N. N., Padinhateeri, R., & Maji, S. K. (2014) · Biochemistry · doi:10.1021/bi500825d · Cited by 69
Progression of alpha‐synuclein pathology in multiple system atrophy of the cerebellar type
Brettschneider, J., Irwin, D. J., Boluda, S., Byrne, M., Fang, L., Lee, E. B., Robinson, J. L., Suh, E. R., Deerlin, V. M. V., Toledo, J. B., et al. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12362 · Cited by 70
Non-polyphenolic natural inhibitors of amyloid aggregation
Ma, L., Yang, C., Zheng, J., Chen, Y., Xiao, Y., & Huang, K. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112197 · Cited by 66
Milk Processing Affects Structure, Bioavailability and Immunogenicity of β-lactoglobulin
Broersen, K. (2020) · Foods · doi:10.3390/foods9070874 · Cited by 66
Structural and functional brain connectome in motor neuron diseases
Basaia, S., Agosta, F., Cividini, C., Trojsi, F., Riva, N., Spinelli, E. G., Moglia, C., Femiano, C., Castelnovo, V., Canu, E., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010731 · Cited by 68
Autophagy-Dependent Secretion: Crosstalk between Autophagy and Exosome Biogenesis
Zubkova, E., Kalinin, A., Bolotskaya, A., Beloglazova, I. B., & Menshikov, M. Y. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46030142 · Cited by 68
Prion-like mechanisms and potential therapeutic targets in neurodegenerative disorders
Hasegawa, M., Nonaka, T., & Masuda‐Suzukake, M. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.11.010 · Cited by 71
β-Amyloid Induces Pathology-Related Patterns of Tau Hyperphosphorylation at Synaptic Terminals
Wu, H., Kuo, P.-C., Wang, Y.-T., Lin, H.-T., Roe, A. D., Wang, B. Y., Han, C., Hyman, B. T., Chen, Y., & Tai, H. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly059 · Cited by 72
Winsky‐Sommerer, R., de Oliveira, P., Loomis, S., Wafford, K. A., Dijk, D., & Gilmour, G. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.027 · Cited by 69
Cohen, M. L., Appleby, B. S., & Safar, J. (2016) · Prion · doi:10.1080/19336896.2015.1123371 · Cited by 66
Impact of Tau on Neurovascular Pathology in Alzheimer's Disease
Canepa, E., & Fossati, S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.573324 · Cited by 67
Anti-aging treatments slow propagation of synucleinopathy by restoring lysosomal function
Kim, D., Lim, H.-S., Kawasaki, I., Shim, Y., Vaikath, N. N., El‐Agnaf, O. M. A., Lee, H.-J., & Lee, S. (2016) · Autophagy · doi:10.1080/15548627.2016.1207014 · Cited by 67
Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression
Ruiz‐Riquelme, A., Lau, H. H. C., Stuart, E., Goczi, A. N., Wang, Z., Schmitt‐Ulms, G., & Watts, J. C. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0529-x · Cited by 69
Prion-like mechanisms in Alzheimer disease
Walker, L. C. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63945-5.00016-7 · Cited by 67
Self-citationModels of Network Spread and Network Degeneration in Brain Disorders
Raj, A., & Powell, F. (2018) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2018.07.012 · Cited by 67
Binding modes of thioflavin T and Congo red to the fibril structure of amyloid-β(1–42)
Frieg, B., Gremer, L., Heise, H., Willbold, D., & Gohlke, H. (2020) · Chemical Communications · doi:10.1039/d0cc01161d · Cited by 65
Rey, N. L., George, S., & Brundin, P. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12299 · Cited by 67
Structure–Property–Activity Relationships in Carbon Dots
Zhou, Y., Zhang, W., & Leblanc, R. M. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c06856 · Cited by 64
Mahanta, S. K., Paul, S., Srivastava, A., Pastor, A., Kundu, B., & Chaudhuri, T. K. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.04.017 · Cited by 65
Beekes, M., Thomzig, A., Schulz‐Schaeffer, W., & Burger, R. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1324-9 · Cited by 67
Order and disorder in the physiological membrane binding of α-synuclein
Fusco, G., Sanz-Hernández, M., & Simone, A. D. (2017) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2017.09.004 · Cited by 64
Aggregation Properties of the Small Nuclear Ribonucleoprotein U1-70K in Alzheimer Disease
Diner, I., Hales, C. M., Bishof, I., Rabenold, L., Duong, D. M., Yi, H., Laur, O., Gearing, M., Troncoso, J., Thambisetty, M., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.562959 · Cited by 63
Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson’s disease
Lobanova, E., Whiten, D. R., Ruggeri, F. S., Taylor, C. G., Kouli, A., Xia, Z., Emin, D., Zhang, Y. P., Lam, J. Y. L., Williams‐Gray, C. H., et al. (2021) · Brain · doi:10.1093/brain/awab306 · Cited by 65
Covell, D. J., Robinson, J. L., Akhtar, R. S., Grossman, M., Weintraub, D. A., Bucklin, H. M., Pitkin, R. M., Riddle, D. M., Yousef, A., Trojanowski, J. Q., et al. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12402 · Cited by 64
Carbonell, F., Iturria‐Medina, Y., & Evans, A. C. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00037 · Cited by 65
Molecular mechanisms of proteinopathies across neurodegenerative disease: a review
Marsh, A. (2019) · Neurological Research and Practice · doi:10.1186/s42466-019-0039-8 · Cited by 64
Monogenic causes of stroke: now and the future
Tan, R. Y. Y., & Markus, H. S. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7794-4 · Cited by 65
The expanding repertoire of ESCRT functions in cell biology and disease
Hurley, J. H., Coyne, A. N., Miączyńska, M., & Stenmark, H. (2025) · Nature · doi:10.1038/s41586-025-08950-y · Cited by 65
van Dis, V., Kuijpers, M., Haasdijk, E. D., Teuling, E., Oakes, S. A., Hoogenraad, C. C., & Jaarsma, D. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-38 · Cited by 66
Jung, B. C., Lim, Y.-J., Bae, E.-J., Lee, J. S., Choi, M. S., Lee, M. K., Lee, H.-J., Kim, Y. S., & Lee, S. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.1 · Cited by 62
Astroglial and microglial contributions to iron metabolism disturbance in Parkinson's disease
Song, N., Wang, J., Jiang, H. F., & Xie, J. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.008 · Cited by 63
Ast, A., Buntru, A., Schindler, F., Hasenkopf, R., Schulz, A., Brusendorf, L., Klockmeier, K., Grelle, G., McMahon, B., Niederlechner, H., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.032 · Cited by 65
Transthyretin Aggregation Pathway toward the Formation of Distinct Cytotoxic Oligomers
Dasari, A. K. R., Hughes, R. M., Wi, S., Hung, I., Gan, Z., Kelly, J. W., & Lim, K. H. (2019) · Scientific Reports · doi:10.1038/s41598-018-37230-1 · Cited by 64
Prion-Like Polymerization in Immunity and InflammationPreprint
Cai, X., Xu, H., & Chen, Z. J. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023580 · Cited by 63
Selective lowering of synapsins induced by oligomeric α-synuclein exacerbates memory deficits
Larson, M. E., Greimel, S. J., Amar, F., LaCroix, M., Boyle, G., Sherman, M. A., Schley, H., Miel, C., Schneider, J. A., Kayed, R., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704698114 · Cited by 61
From nucleation to widespread propagation: A prion-like concept for ALS
Maniecka, Z., & Polymenidou, M. (2015) · Virus Research · doi:10.1016/j.virusres.2014.12.032 · Cited by 65
Lange, S., Gallagher, M., Kholia, S., Kosgodage, U. S., Hristova, M., Hardy, J., & Inal, J. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061196 · Cited by 62
Gill, O. N., Spencer, Y. I., Richard-Loendt, A., Kelly, C., Brown, D. W., Sinka, K., Andrews, N. J., Dabaghian, R. H., Simmons, M. M., Edwards, P., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02153-7 · Cited by 63
On the central role of brain connectivity in neurodegenerative disease progression
Iturria‐Medina, Y., & Evans, A. C. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00090 · Cited by 62
Distinctive pathological mechanisms involved in primary progressive aphasias
Leyton, C. E., Britton, A. K., Hodges, J. R., Halliday, G. M., & Kril, J. J. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.017 · Cited by 63
Masnata, M., Sciacca, G., Maxan, A., Bousset, L., Denis, H. L., Lauruol, F., David, L. S., Saint‐Pierre, M., Kordower, J. H., Melki, R., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01973-6 · Cited by 64
Microbiome Influence in the Pathogenesis of Prion and Alzheimer’s Diseases
D’Argenio, V., & Sarnataro, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194704 · Cited by 64
Direct measurement of lipid membrane disruption connects kinetics and toxicity of Aβ42 aggregation
Flagmeier, P., De, S., Michaels, T. C. T., Yang, X., Dear, A. J., Emanuelsson, C. S., Vendruscolo, M., Linse, S. S., Klenerman, D., Knowles, T. P. J., et al. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-0471-z · Cited by 63
Is γ-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?
Checler, F., Afram, E., Pardossi‐Piquard, R., & Lauritzen, I. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100489 · Cited by 63
The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial
Dalla Bella, E., Bersano, E., Antonini, G., Borghero, G., Capasso, M., Caponnetto, C., Chiò, A., Corbo, M., Filosto, M., Giannini, F., et al. (2021) · Brain · doi:10.1093/brain/awab167 · Cited by 59
Li, Q. S., & Muynck, L. D. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100227 · Cited by 60
Metadata
- Authors
- Jucker, M., & Walker, L. C.
- Affiliations
- Hertie Institute for Clinical Brain Research (DE)
- Emory University (US)
- Corresponding author
- Jucker, Mathias
- Walker, Lary C.
- Venue
- Nature
- Published
- 2013-09-04
- Volume
- 501
- Issue
- 7465
- Pages
- 45-51
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3963807
- OpenAlex
- W2034147064
- Cited by
- 1,663
- References
- 126
- Citations by year
- 2026: 82 · 2025: 113 · 2024: 114 · 2023: 111 · 2022: 119 · 2021: 161 · 2020: 140 · 2019: 153 · 2018: 131 · 2017: 166 · 2016: 147 · 2015: 119 · 2014: 101 · 2013: 6
- FWCI
- 11.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DZNE Pub (submittedVersion)
- Funders
- National Institutes of Health (P51OD011132)
- National Institute on Aging (R21AG040589)
- National Center for Research Resources (P51RR165, P51RR000165)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- protein aggregation, seeded aggregation, neurodegenerative diseases, prion disease, Alzheimer's disease, Parkinson's disease, Creutzfeldt-Jakob disease, protein misfolding, amyloid, oligomers, proteinopathies, disease models, neurodegeneration therapy
- MeSH terms
- Alzheimer Disease, Amyloid, Animals, Humans, Prions, tau Proteins, Prion Diseases, Neurodegenerative Diseases, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
